首页|激活MrgC受体抑制骨癌痛大鼠脊髓背角和背根神经节神经化学改变

激活MrgC受体抑制骨癌痛大鼠脊髓背角和背根神经节神经化学改变

扫码查看
癌症疼痛是晚期癌症患者最常见的症状之一。本研究旨在探讨MrgC(Mas-related gene C)受体对骨癌痛的影响。将Walker 256乳腺癌细胞接种至成年Sprague-Dawley大鼠胫骨制备骨癌痛模型,以机械撤足阈值和热撤足阈值观察其痛觉超敏情况。在第16天和第17天鞘内注射MrgC受体激动剂牛肾上腺髓质8-22(bovine adrenal medulla 8-22,BAM8-22),观察其对机械刺激和热刺激等伤害性行为的影响。用免疫荧光染色方法检测脊髓背角胶质纤维酸性蛋白(glial fibrillary acidic protein,GFAP)阳性细胞以及背根神经节(dorsal root ganglia,DRG)中降钙素基因相关肽(calcitonin gene related peptide,CGRP)、神经元型一氧化氮合酶(neuronal nitric oxide synthase,nNOS)和IL-1β阳性神经元数量变化。用另一种MrgC受体激动剂(Tyr6)-γ2-MSH-6-12(MSH)同样处理后,通过蛋白质印迹法检测脊髓背角和DRG中nNOS和IL-1β蛋白的表达。结果显示,鞘内注射BAM8-22(30nmol)减轻了大鼠骨癌痛模型中的机械痛觉超敏,即时效果可持续约60min,连续两天单次给药BAM8-22在第三天减轻了约一半的机械痛阈。此外,脊髓背角中的GFAP阳性细胞以及DRG中CGRP、nNOS和IL-1β阳性神经元的数量也减少。同样,鞘内给予MSH(15nmol)降低了脊髓背角和DRG中nNOS和IL-1β的表达。结果提示,激活MrgC受体有可能通过抑制脊髓背角星形胶质细胞的激活以及脊髓背角和/或DRG中CGRP、nNOS和IL-1β的表达来减轻骨癌痛。这些发现有望为骨癌痛的治疗提供新策略。
Mas-related gene C(MrgC)receptor activation induced inhibition of neurochemical alterations in the spinal dorsal horn and dorsal root ganglia in a rat model of bone cancer pain
Cancer pain is one of the most common symptoms in patients with advanced cancer.In this study,we aimed to investigate the effects of the Mas-related gene C(MrgC)receptors on bone cancer pain.Mechanical withdrawal threshold(MWT)and thermal withdrawal latency(TWL)were measured after the inoculation of Walker 256 mammary gland carcinoma cells into the tibia of adult Sprague-Dawley rats.The effects of MrgC receptor agonist bovine adrenal medulla 8-22(BAM8-22)on nociceptive behaviors were investigated after intrathecal injection on days 16 and 17.Glial fibrillary acidic protein(GFAP)-positive cells in the spinal dorsal cord,and calcitonin gene related peptide(CGRP)-,neuronal nitric oxide synthase(nNOS)-and IL-1β-positive neurons in the dorsal root ganglia(DRG)were examined by immunofluorescence staining.The expression of nNOS and IL-1β proteins in the spinal dorsal horn and the DRG was examined by Western blotting after treatment with(Tyr6)-γ2-MSH-6-12(MSH),which was another MrgC receptor agonist.The results showed that intrathecal injection of BAM8-22(30 nmol)attenuated mechanical allodynia in a rat model of bone cancer pain and the effects could last for about 60 min,and single administration of BAM8-22 for two consecutive days reduced mechanical allodynia by about half on the third day.Moreover,the number of GFAP-positive cells in the spinal dorsal horn,and the number of CGRP-,nNOS-and IL-1β-positive neurons in the DRG were decreased.Similarly,intrathecal administration of MSH(15 nmol)reduced the expression of nNOS and IL-1 β in the spinal dorsal horn and the DRG.In conclusion,activation of MrgC receptors suppresses the activation of astrocytes in the spinal dorsal cord and the expression of CGRP,nNOS,and IL-1β in the spinal dorsal cord and/or DRG,which may underlie the inhibition of bone cancer pain.These findings provide a novel strategy for the treatment of bone cancer pain.

Mas-related gene C(MrgC)receptorsallodyniaspinal dorsal horndorsal root ganglion(DRG)neurochemistrybone cancer pain

江剑平、张科、胡粉娟、洪炎国

展开 >

福建师范大学生命科学学院

福建省发育和神经生物学重点实验室,福州 350117

MrgC受体 痛觉超敏 脊髓背角 背根神经节 神经化学 骨癌痛

2024

生理学报
中国科学院上海生命科学研究院,中国生理学会

生理学报

CSTPCD北大核心
影响因子:0.864
ISSN:0371-0874
年,卷(期):2024.76(6)